KY HB713 | 2024 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 26 2024 - 25% progression, died in committee
Action: 2024-02-26 - to Committee on Committees (H)
Pending: House Committee On Committees Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 26 2024 - 25% progression, died in committee
Action: 2024-02-26 - to Committee on Committees (H)
Pending: House Committee On Committees Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for FDA-approved prescription drugs for the treatment of postpartum mood disorders; amend KRS 164.2871, 205.522, 205.6485, and 18A.225 to require a self-insured employer group health plan provided by a state postsecondary education institution to its employees, Medicaid, and Kentucky Children's Health Insurance Program to comply with the new section on postpartum mood disorder coverage; direct that provisions apply to health benefit plans issued on or after January 1, 2025; EFFECTIVE January 1, 2025.
Title
AN ACT relating to coverage for the treatment of postpartum mood disorders.
Sponsors
History
Date | Chamber | Action |
---|---|---|
2024-02-26 | House | to Committee on Committees (H) |
2024-02-26 | House | introduced in House |
Subjects
Actuarial Analysis
Children and Minors
Drugs and Medicines
Education, Higher
Effective Dates, Delayed
Health Benefit Mandate
Insurance, Health
Local Mandate
Medicaid
Mental Health
Reproductive Issues
State Employees
Women
Children and Minors
Drugs and Medicines
Education, Higher
Effective Dates, Delayed
Health Benefit Mandate
Insurance, Health
Local Mandate
Medicaid
Mental Health
Reproductive Issues
State Employees
Women